KEAP1 and cancer: KEAP1 mutations were predominantly identified in NSCLC cell lines (Fig. S1B) and patients (Fig. S1C), and have also been detected in several other cancer types, including liver, ovarian, and uterine cancers (Fig. S1B, C).